Please provide your email address to receive an email when new articles are posted on . Aura Biosciences announced positive visual acuity results from a phase 1b/2 trial of its cancer drug AU-011 in ...
The FDA’s Office of Prescription Drug Promotion sent Travere Therapeutics a letter over its advertising for Filspari, a drug that’s approved to slow kidney function decline in people with primary IgA ...
Increased formulation viscosity narrows tolerances in prefilled syringe filling, demanding precise, gentle control of temperature, pressure, shear forces, and pump speed to protect biologic integrity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results